Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Preferred Stock Liabilities (2019 - 2020)

Cellebrite DI's Preferred Stock Liabilities history spans 2 years, with the latest figure at $101.2 million for Q4 2020.

  • Quarterly Preferred Stock Liabilities changed 0.0% to $101.2 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $101.2 million through Dec 2020, changed 0.0% year-over-year, with the annual reading at $101.2 million for FY2020, 0.0% changed from the prior year.
  • Preferred Stock Liabilities came in at $101.2 million for Q4 2020, roughly flat from $101.2 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $101.2 million in Q4 2019 to a low of $101.2 million in Q4 2019.